Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$90.62 USD
-1.03 (-1.12%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $90.59 -0.03 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Zimmer Biomet Holdings, Inc. has a PEG ratio of 2.16 compared to the Medical - Products industry's PEG ratio of 2.14.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ZBH 90.62 -1.03(-1.12%)
Will ZBH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZBH
Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know
Analysts Estimate Zimmer Biomet (ZBH) to Report a Decline in Earnings: What to Look Out for
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal
ISRG Expands Installed Base, But Is Utilization Keeping Pace?
Other News for ZBH
Franklin Mutual Quest Fund Q2 2025 Commentary
What Does the Market Think About Zimmer Biomet Holdings?
Franklin Mutual Shares Fund Q2 2025 Commentary
Franklin Mutual Global Discovery Fund Q2 2025 Commentary
P/E Ratio Insights for Zimmer Biomet Holdings